Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Rhea-AI Summary

Artivion (NYSE: AORT) has scheduled the release of its first quarter 2025 financial results for Monday, May 5, 2025, after market close. The cardiac and vascular surgery company will host a teleconference call and live webcast at 4:30 p.m. ET on the same day.

The earnings discussion will feature a Q&A session led by Pat Mackin, Chairman, President and CEO. Interested parties can join the teleconference by dialing 201-689-8261 before 4:30 p.m. ET. A replay will be available at 877-660-6853 or 201-612-7415 (conference number: 13752340). The webcast and replay can be accessed through the Investors section at www.artivion.com under Webcasts & Presentations.

ATLANTA, April 21, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2025 financial results will be released on Monday, May 5, 2025, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13752340. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion Lance A. Berry Executive Vice President & Chief Financial Officer Phone: 770-419-3355	Gilmartin Group LLC Brian Johnston / Laine Morgan Phone: 332-895-3222 investors@artivion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2025-financial-results-302433639.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release Q1 2025 earnings?

Artivion will release Q1 2025 earnings on Monday, May 5, 2025, after market close.

How can investors join Artivion's Q1 2025 earnings call?

Investors can dial 201-689-8261 before 4:30 p.m. ET on May 5, 2025, to join the earnings call.

What is the replay number for Artivion's Q1 2025 earnings call?

The replay numbers are 877-660-6853 (toll-free) or 201-612-7415, with conference number 13752340.

Where can I find Artivion's Q1 2025 earnings webcast?

The webcast can be accessed in the Investors section of www.artivion.com under Webcasts & Presentations.